Researchers have found that an alcohol support group, such as Alcoholics Anonymous, when combined with other treatments is much more effective in getting the alcoholic to stay sober. Folks afflicted with rheumatoid arthritis normally have discomfort caused by inflammation…
Bayer bags swift OK for Nubeqa in metastatic prostate cancer
Bayer has won a key FDA approval to extend the use of its prostate cancer therapy Nubeqa, as it tries to claim market share from rival drugs and fulfil its aim of building the drug into a €3 billion ($3.1…
US Democrats’ blockbuster budget bill could spell big changes for drug prices
The Inflation Reduction Act of 2022, a sweeping measure that now looks likely to be passed through budget reconciliation by Senate Democrats in the US, contains measures intended to greatly reduce US prescription drug prices — but the pharma lobby…
Government to support agri field, clinical trials for new technologies
The Technology Development Board (TDB) under the Department of Science and Technology will start extending funds for agricultural field trials and clinical trials for new technologies, according to Rajesh Kumar Pathak, Secretary of TDB. At a meeting on “Financial Assistance…
Poseida, Roche collaborate on allogeneic CAR-T Cell therapies
The collaboration will focus on advancing multiple existing and additional next-generation cell therapies against targets in multiple myeloma, B-cell lymphomas and other hematologic indications Poseida Therapeutics and Roche have entered into a strategic collaboration and license agreement to develop allogeneic…
Amgen to acquire rare diseases drugmaker Chemocentryx for $4bn
Amgen will gain access to Tavneos, Chemocentryx’s oral small molecule drug, designed to selectively inhibit the complement component 5a receptor (C5aR), to treat autoimmune and inflammatory diseases Amgen has signed a definitive agreement to acquire ChemoCentryx, a biopharmaceutical company focused…
Gilead Sciences to acquire UK biotechnology firm MiroBio for $405m
Through the acquisition, Gilead will obtain MiroBio’s unique I-ReSToRE drug discovery platform, along with its complete range of investigational immune inhibitory receptor agonist therapies US-based biopharmaceutical firm Gilead Sciences has signed a definitive agreement to acquire all of the…
Allergan Aesthetics gets FDA nod for Juvéderm Volux XC to improve jawline definition
Juvéderm Volux XC is said to be the first and only hyaluronic acid (HA) filler to receive US FDA approval for improving jawline definition, and sixth product in the company’s Juvéderm family of fillers Allergan Aesthetics, a subsidiary of AbbVie,…
